Medicinal products for human use: implementation of good clinical practice in the conduct of clinical trials

The European Parliament approved, with a number of compromise amendments, the resolution by Mr Peter LIESE (EPP/ED, D) on the Council's common position. Commissioner Michel BARNIER said he could also accept these compromise amendments. For a long time, the European Parliament and Council positions had been very different but a detailed agreement has been finally reached. Key points of the compromise amendments were that necessary research will be allowed but that 'trial subjects' are ensured maximum protection. In order to implement the agreement, Parliament adopted a large number of compromise amendments. These are mirrored in the decision of the committee responsible. (Refer to the previous document).�